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Edited by Sandro SonninoAbstract Studies [Zhou, D., Chen, L.-M., Hernandez, L.,
Shears, S.B., and Gala´n, J.E. (2001) A Salmonella inositol
polyphosphatase acts in conjunction with other bacterial eﬀectors
to promote host-cell actin cytoskeleton rearrangements and bac-
terial internalization. Mol. Microbiol. 39, 248–259] with engi-
neered Salmonella mutants showed that deletion of SopE
attenuated the pathogen’s ability to deplete host-cell InsP5 and
remodel the cytoskeleton. We pursued these observations: In
SopE-transfected host-cells, membrane ruﬄing was induced,
but SopE did not dephosphorylate InsP5, nor did it recruit PTEN
(a cytosolic InsP5 phosphatase) for this task. However, PTEN
strengthened SopE-mediated membrane ruﬄing. We conclude
SopE promotes host-cell InsP5 hydrolysis only with the assis-
tance of other Salmonella proteins. Our demonstration that Sal-
monella-mediated cytoskeletal modiﬁcations are independent of
inositolphosphates will focus future studies on elucidating alter-
nate pathogenic consequences of InsP5 metabolism, including
ion channel conductance and apoptosis.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Salmonella is an important enteric pathogen of humans and
a variety of domestic and wild animals. Infection is initiated in
the intestinal tract, and severe disease produces widespread
destruction of the intestinal mucosa. Salmonella strains can
also disseminate from the intestine and produce serious, some-
times fatal infections in a number of systemic organs [1].
When Salmonella invades cells, it hijacks a number of the
host’s cellular signaling systems [2,3]. One dramatic example
is the rapid depletion of the cellular InsP5 pool [4–6]. In fact,
no other stimulus is known that can elicit changes in cellular
InsP5 levels at either the rate or the magnitude of that stimu-
lated by Salmonella. InsP5 is a ‘‘hub’’ that serves several cell-
signaling pathways [7], and the acute changes in its cellular
levels may contribute to the pathogenicity of Salmonella in
three major ways.*Corresponding author. Fax: +919 541 0559.
E-mail address: shears@niehs.nih.gov (S.B. Shears).
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doi:10.1016/j.febslet.2006.02.019First, it has been suggested that the levels of InsP5 in host-
cells may aﬀect the development of membrane ruﬄing and
lamellapodial extensions that envelop Salmonella and allow
the bacteria to invade the cell [3,4]. This is a plausible role
for InsP5 because the dynamics of the actin cytoskeleton are
regulated by groups of proteins containing pleckstrin homol-
ogy (PH) domains [8]. PH-domain proteins often bind both
inositol phosphates and inositol lipids; the subcellular distribu-
tion of these proteins can be aﬀected by changes in the degree
of competition between the two classes of ligands [9–11]. Thus,
perturbation of the inositol phosphate proﬁle in host-cells may
aﬀect the actions of proteins that control the architecture of
the actin cytoskeleton [4,12]. Indeed, genetically engineered
Salmonella mutants that cannot dephosphorylate InsP5 are
also unable to form membrane ruﬄes and cannot enter cells
[4,5].
Second, InsP5 is a pro-apoptotic antagonist of the Akt pro-
tein kinase [9]. Therefore, loss of cellular InsP5 may underlie
the ability of Salmonella to activate Akt and promote cell sur-
vival during infection [13]. Third, InsP5 dephosphorylation to
Ins(1,4,5,6)P4 perturbes K
+ and Cl channel conductances
[5,14,15]. This may aﬀect apoptosis [16], and, in the case of
intestinal epithelial cells, changes in ionic conductances can
augment salt and ﬂuid secretion into the intestinal tract,
which may underlie the secretory diarrhoea that the pathogen
induces.
It has therefore become important to understand the molec-
ular mechanisms by which Salmonella alters inositol phosphate
turnover in the host-cell. Two bacterial proteins have appeared
to contribute to this phenomenon. First, SopB (also known as
SigD), has a phosphatase domain that can directly hydrolyze
InsP5 [4,6]. Furthermore, a sopB
 strain of S. typhimurium
was found to be less eﬀective than the wild-type strain at
dephosphorylating intracellular InsP5 [4]. In addition, it has
been shown that cellular InsP5 depletion is also attenuated in
a sopE strain of S. typhimurium [4]. Thus, it is believed that
SopE in some way facilitates InsP5 dephosphorylation. The
sopE strain is also less eﬀective than the wild-type strain at
initiating membrane ruﬄes, which has given further support
to the idea that increased InsP5 metabolism is directly associ-
ated with cytoskeletal changes [4].
However, it is diﬃcult to unravel the various molecular
mechanisms driving the multitude of diﬀerent host/pathogen
interactions. Since multiple ‘‘attack’’ pathways are invoked,
the fact that they might coincide temporally does not necessar-
ily mean that they are directly functionally coupled. Thus, in
the current study, we have directly investigated the role ofblished by Elsevier B.V. All rights reserved.
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tained the extent to which this is linked to cytoskeletal
rearrangements. Our approach has been to study these two cel-
lular responses after transfecting host-cells with SopE.
A variety of cell-types have previously been used to study the
molecular mechanisms underlying Salmonella pathogenicity
[17–20]. The choice of cell-type for the current study was dri-
ven by an appreciation that the SopE protein might not hydro-
lyze InsP5 directly, but might instead recruit a host-cell InsP5
phosphatase [4,12]. In mammalian cells, there is only one cyto-
solic candidate with this activity, namely, PTEN [21,22]. To
investigate if PTEN is recruited for this role, it was necessary
to use a model system in which we could investigate the eﬀects
upon InsP5 levels in both the absence of PTEN, and in the
presence of a physiologically relevant level of PTEN. We there-
fore studied the eﬀects of SopE upon a PTEN-null, human
glioblastoma, U87MG [23,24], which has been used as a host
for a muristerone-inducible PTEN gene [23,25].2. Materials and methods
2.1. Materials
[3H]InsP5 was prepared as previously described [21]. Non-radioac-
tive Ins(1,3,4,5,6)P5 was purchased from CellSignals (Columbus
OH). Dr. Mike Myers, Cold Spring Harbor Laboratory, NY, supplied
the U87MG cells that were used as hosts for the PTEN gene under the
control of a muristerone promoter [23]. Gene expression was induced
by adding 0.5 lM muristerone to the culture medium for 48 h.
U87MG cells were cultured in 60 mm dishes in DMEM, supplemented
with 10% FBS, 1% penicillin/streptomycin and 1% Na pyruvate. Re-
combinant GST-SopB and GST-SopE were kindly provided by Drs.
Daoguo Zhou and Jorge Gala´n, Yale School of Medicine, New Haven,
CT. Dr. Gala´n also kindly provided the SopE78–240 construct in a
pSG5 vector, and the SopB construct in a pSB965 vector. Cells were
transfected using LipofectAMINE 2000 Reagent (GibcoBRL) in
accordance with the manufacturer’s instructions.
2.2. Inositol phosphate assays
The U87MG cells were radiolabeled for 3 days with 25 lCi/ml
[3H]inositol (American Radiolabeled Chemicals, St. Loius, MO). At
the appropriate times, the media was aspirated and the inositol phos-
phates were then extracted from the cells using perchloric acid as pre-
viously described [26]. The acid-soluble extracts were neutralized with
potassium carbonate, and the inositol phosphates were resolved by an-
ion-exchange HPLC as previously described, using phosphate-based
elution systems and a SynChropak Q100 SAX column [27,28]. The
radioactivity was assessed either ‘‘on-line’’ using a Flo-1 counter
(Packard Instruments), whereupon data were processed using Flo-1
for Windows (v 3.61) and then exported into SigmaPlot (v 8.0) as an
ASCII ﬁle. In some other experiments, 1 ml fractions were collected
from the HPLC eluate. Levels of inositol phosphates (D.P.M.) in each
sample were normalized to the level of inositol lipids (see below). For
the analysis of [3H]InsP5 metabolism in vitro, assays were quenched
with perchloric acid, neutralized, and chromatographed on gravity-
fed anion-exchange columns [26].
2.3. Inositol lipid assays
For some experiments, levels of PtdIns(4,5)P2 and PtdIns(3,4,5)P3
were determined as follows: The medium was aspirated from the
[3H]inositol-labeled cells (see above), which were then quenched with
2 ml 1 M HCl. Then, 10 ll of a phosphoinositide mixture (25 mg/ml
in 1:1 (v/v) chloroform/methanol; Sigma) was added, and the [3H]ino-
sitol lipids were extracted [29], deacylated [30], and chromatographed
on a 250 · 4.6 mm Partisphere SAX HPLC column [31]. [3H]GroPtd-
Ins(4,5)P2 standards were generated from [
3H]PtdIns(4,5)P2 (Perkin–
Elmer, Boston, MA); the [3H]GroPtdIns(3,4,5)P3 peak was identiﬁed
from its known elution position [31] and by virtue of its levels increas-
ing 45-fold as a consequence of cell activation for 5 min with 30 ng/ml
of PDGF-BB (R&D system, MN) (data not shown). In other experi-ments, the perchloric acid-insoluble extracts from [3H]inositol-labeled
cells (obtained as described above) were digested overnight at 4 C
with 1 ml of 100 mM NaOH plus Triton (0.1 %) to solubilize all of
the inositol lipids (for normalization of the inositol phosphate data,
see above).
2.4. Western blot analysis
Cells were lysed with M-PER Mammalian Protein Extraction Re-
agent (Pierce, IL) supplemented with protease inhibitor cocktail
(Roche Diagnostics Corp.) and phosphatase inhibitor mixture (Calbio-
chem). Lysates were cleared by centrifugation at 4 C and protein con-
centration was quantiﬁed by using the Bio-Rad protein assay (Bio-Rad
Laboratories). Equal amounts of protein (40 lg) were resolved on Nu-
PAGE 4–12% pre-cast gel (NOVEX, San Diego, CA) which were sub-
sequently transferred to PVDF membranes. PTEN was detected by
using anti-Human PTEN monoclonal antibody (Cascade, MA,
1:2000 dilution). The HRP-linked secondary antibody (Cell Signaling,
MA) was used at 1:7000 dilution. Blots were then stripped using
100 mM 2-mercaptoethanol, 2% SDS and 62.5 mM Tris–HCl (pH
6.8). The membrane was then probed with anti-human GAPDH anti-
body (Ambion TX, 1:14000 dilution) followed by secondary antibody
as described above. Blots were developed using Western blot Chemilu-
minescence Reagent Plus (NEN Life Science Products).
2.5. Confocal immunoﬂuorescence microscopy
All incubation and wash buﬀers contained phosphate-buﬀered saline
at pH 7.4 (PBS). Cells, grown to subconﬂuence on coverslips, were
washed and ﬁxed in PBS containing 3% paraformaldehyde for
15 min at 4 C. Cells were washed three times, permeabilized with
1% Triton X-100 for 5 min at room temperature, washed three times,
blocked with 1% bovine serum albumin for 30 min at room tempera-
ture, and washed three times. For analysis of the membrane ruﬄing,
cells were incubated with Texas Red-X phalloidin (Molecular Probes,
cat No. T-7471) at a 1:20 dilution for 20 min at room temperature, fol-
lowed by three more washes. The Prolong Antifade kit (Molecular
Probes, cat No. P-7481) was used to extend the useful lives of the ﬂuo-
rescent probes. Images were obtained using a laser scanning confocal
microscope (LSM 410, Carl Zeiss, Inc., Thornwood, NY) mounted
on an inverted microscope (Axiovert 135, Zeiss). The objective lens
was a C-Apo 40· 1.2 numerical aperture water immersion lens (Zeiss).
At a pinhole setting of 16, a z resolution of 1.1 lm was obtained. For
the green ﬂuorescent protein and actin images, the GFP and Texas-
Red (representing actin) were excited independently with the 488-
and 568-nm (respectively) laser lines of the attached Ar-Kr laser
(Melles Griot, Carlsbad, CA). GFP ﬂuorescence was collected with a
515–540-nm band pass ﬁlter and Texas Red-X ﬂuorescence with a
610-nm long pass ﬁlter. Representative cells are shown in the ﬁgures.
All images are projections of z-stacks with the exception of the GFP
image in Fig. 5, which is a single confocal slice. A smoothing ﬁlter
was applied to all GFP images. Contrast enhancement was performed
separately on all images so that they all would have approximately the
same background and the same level of saturation. All image process-
ing was done using LSM Image Examiner 3.5 for Windows (Zeiss).
Representative cells are shown in the ﬁgures.3. Results and discussion
3.1. Comparison of the InsP5 phosphatase activities of
recombinant SopE and SopB
It has previously been shown that a sopE strain of S.
typhimurium was less eﬀective than the wild-type strain at both
promoting the formation of membrane ruﬄes and dephospho-
rylating host-cell InsP5 [4]. This naturally led to the proposal
that InsP5 metabolism and membrane ruﬄing were function-
ally connected, and that SopE contributed to both phenomena
[4]. The SopE protein has no apparent phosphatase consensus
sequence, but other precedents argue that, by itself, lack of
such sequence homology does not exclude the protein having
a phosphatase function. For example, the amino-acid sequence
of SopE does not reveal the presence of the Dbl homology and
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SopE can act as a GEF [18,32]. We therefore examined
whether recombinant SopE protein could dephosphorylate
InsP5 in vitro.
The positive control for this experiment was recombinant
SopB, which has previously been shown to hydrolyze InsP5
in vitro [4,6]. SopB and SopE were separately incubated with
10 lM [3H]-labeled InsP5 for various times, and then the reac-
tions were analyzed by ion-exchange chromatography (Fig. 1).
A ‘‘batch’’ elution protocol was employed to separate InsP4
product from the InsP5 substrate; a slight (2.2%) spillover of
the InsP5 into the InsP4 fraction was observed in zero time as-[ 3
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Fig. 1. Reactivity of SopB and SopE towards InsP5 in vitro.
Recombinant GST-SopB (0.12 mg/ml ﬁnal concentration) or GST-
SopE (1.1 mg/ml ﬁnal concentration) was incubated at 30 C for 0–
40 min in 25 ll of assay buﬀer containing 50 mM HEPES (pH 7.2),
10 mM DTT, 0.35 mg/ml bovine serum albumin. Assays were
quenched and neutralized as described in Section 2 and the InsP4
product was separated from the InsP5 substrate by batch ion-exchange
chromatography [26]. Data shown are triplicates from a representative
experiment that was repeated four times with identical results. In other
experiments (not shown) SopE also did not dephosphorylate InsP5
when the assay buﬀer was supplemented with 2 mM MgSO4.
Fig. 2. Transient expression of SopE in PTEN-null glioblastomas induces th
null U87MG glioblastoma cells were either mock-transfected (‘‘control’’, left
were labeled with Texas Red-X Phalloidin, to identify actin. The yellow arrow
In the right-hand panel the green colour shows GFP ﬂuorescence in cells in th
image represents 20 lm.says (Fig. 1). Exactly the same spillover was observed in assays
containing 1.1 mg/ml SopE, indicating that there was no InsP5
metabolism (Fig. 1). In contrast, up to 15% of added InsP5 was
dephosphorylated to InsP4 in assays that contained SopB, even
though it was added at 10-fold lower concentrations than
SopE (Fig. 1). These data conﬁrm that SopE has no detectable
InsP5 phosphatase activity in vitro.
3.2. The eﬀects of SopE upon InsP5 turnover and membrane
ruﬄing in PTEN-null glioblastomas
Although recombinant SopE did not dephosphorylate InsP5
in vitro (see above), it was still important to determine whether
SopE might have this function in vivo (see Section 1). We there-
fore measured the eﬀects upon InsP5 levels in a mammalian
host-cell following transfection with SopE. We also wanted
to explore the possibility that SopE might hijack the host-cell’s
sole cytosolic InsP5 phosphatase (i.e. PTEN; [21,22]), therefore
we employed a human U87MG glioblastoma cell line that is
PTEN-null [23,24].
We transiently transfected the U87MG PTEN-null cells with
cDNA encoding an N-terminally truncated SopE78240. This
protein has enhanced stability in mammalian cells because it
lacks the lysosomal targeting signal which normally ensures
its rapid degradation, but in all other aspects the truncated
protein is fully functional [33]. Co-transfection with cDNA
for GFP enabled us to identify the cells that were successfully
transfected (Fig. 2); transfection eﬃciency was 50–70%. The
degree of membrane ruﬄing was assessed by confocal micros-
copy of ﬁxed cells that were labeled for ﬁlamentous actin with
Phalloidin conjugated to Texas Red-X (Fig. 2). One indication
that SopE has a signiﬁcant eﬀect upon cellular architecture is
evidenced by the less elongated, more rounded structure of
the transfected cells (Fig. 2). Most of the SopE-transfected
cells typically displayed discrete patches of polymerized actin
at the plasma membrane (highlighted with arrows in Fig. 2).
We also studied the eﬀects of SopE upon InsP5 turnover in
cells that had been radio-labeled with [3H]inositol. After 3
days of labelling, cells were transfected with SopE, and then
the inositol phosphate levels were analyzed by HPLC. Despitee formation of discrete patches of membrane ruﬄing. Human PTEN-
panel), or SopE-transfected (middle and right panels). After 24 h, cells
s highlight the discrete patches of actin that signify membrane ruﬄing.
e same ﬁeld of view as the middle panel. The white scale bar in the GFP
Fig. 4. Induction of PTEN expression in the glioblastoma cells PTEN-
null U87MG glioblastoma cells were treated with either 0.5 lM
muristerone for 48 h or an appropriate volume of the vehicle control.
Cell lysates were prepared and 40 lg of total protein was resolved on a
gel and immunoblotted with antibodies speciﬁc for PTEN or GAPDH.
1712 S. Deleu et al. / FEBS Letters 580 (2006) 1709–1715the fact that, 24 h after transfection, there was a considerable
activation of membrane ruﬄing (Fig. 2), we found no eﬀect of
SopE upon levels of InsP5 or any other inositol phosphate
(Fig. 3A and B). We also assayed InsP5 levels in cells 6 and
12 h after transfection, even though SopE expression would
be low or non-existent at those times [18]. Again, no eﬀect
upon InsP5 levels was observed (Fig. 3C). As a positive con-
trol, we also transfected cells with SopB for 24 h. In three
independent experiments, the levels of InsP5 decreased by
25% (P < 0.002; Fig. 3C). The internal control for these exper-
iments was InsP6, the levels of which were unaﬀected by SopB
([3H]InsP6 levels in control cells = 121 ± 1 D.P.M./D.P.M. lip-
ids · 104; [3H]InsP6 levels in SopB-transfected cells = 114 ± 2
D.P.M./D.P.M. lipids · 104). There was no eﬀect of SopB
transfection upon InsP5 levels after 12 h (data not shown),
consistent with insuﬃcient SopB being expressed after such
a short time. Our data are the ﬁrst to show that the induction
of membrane ruﬄes by SopE is functionally independent of
InsP5 dephosphorylation.
SopE has also been suggested to activate phospholipase C
[4,12]. However, we found no evidence for this, since levels
of InsP1, InsP2 and InsP3 were unaﬀected by SopE transfection
(Fig. 3 and data not shown).
3.3. The eﬀect of PTEN upon InsP5 turnover and membrane
ruﬄing following SopE transfection of glioblastomas
Earlier work with a sopE strain of S. typhimurium raised the
possibility that SopE might recruit a host-cell InsP5 3-phospha-Elution time (min)
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standard errors from three experiments. *P < 0.002.tase [4]. PTEN is the only known cytosolic candidate that has
this activity [21], but that was absent from the cells used in
the experiments described above. Therefore, we next investi-
gated if SopE would aﬀect InsP5 levels when PTEN expression
was induced by treating the U87MG cells with 0.5 lM muris-
terone for 48 h (Fig. 4). Previous data have shown that this level
of PTEN expression is physiologically relevant [23,25]. TheIn
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S. Deleu et al. / FEBS Letters 580 (2006) 1709–1715 1713induction of PTEN brought about the expected decrease in cel-
lular PtdIns(3,4,5)P3 content (see Section 2): the level of
[3H]PtdIns(3,4,5)P3 was 784 ± 98 dpm/dish (n = 3) in vehicle-
treated PTEN-null cells. The corresponding value was
166 ± 40 dpm/dish after our standard muristerone treatment
to induce PTEN. For an internal control, the levels of
[3H]PtdIns(4,5)P2 were also recorded. These were not
signiﬁcantly altered by muristerone treatment (PTEN-
null = 115620 ± 8988 dpm [3H]PtdIns(4,5)P2/dish; PTEN-
expressing = 125654 ± 3264 dpm [3H]PtdIns(4,5)P2/dish).
We found that InsP5 levels in the PTEN-expressing cells did
not decrease after SopE transfection (Fig. 5). Clearly, SopE
does not activate the InsP5 3-phosphatase activity of PTEN.
Another ﬁnding in these experiments was that the SopE-in-
duced membrane ruﬄing in the PTEN-expressing cells
(Fig. 5) tended to extend over a greater surface of the cell mem-
brane, as compared to the more spatially restricted ruﬄing
that was observed in the absence of PTEN (Fig. 3). We have
quantiﬁed this phenomenon by counting the number of
SopE-transfected cells in which membrane ruﬄing was con-
ﬁned to less than 33% of the plasma membrane: This occurred
in 59% of 240 PTEN-null cells but only in 20% of 270 PTEN-
expressing cells. This result of this comparison is somewhat
counter-intuitive, given that PTEN expression, through its
ability to lower PtdIns(3,4,5)P3 levels, might generally be antic-
ipated to inhibit membrane ruﬄing [34,35]. On the other hand,
the extensive membrane ruﬄing that we observed following
transient transfection of SopE in PTEN-expressing cells
(Fig. 5) recapitulates observations made in previous studies
[4,18] in which SopE was transfected into cells with a normalControl SopE
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expression had been induced by 48 h treatment with 0.5 lM muristerone (se
SopE and GFP for a further 24 h. Cells were labeled with Texas Red-X Phallo
radiolabeled with [3H]inositol for 3 days prior to transfection (control or S
analysis. The white scale bar in the GFP image represents 20 lm.complement of PTEN. It could be an important future direc-
tion to determine how this apparent interaction between SopE
and PTEN inﬂuences the nature of the membrane ruﬄing re-
sponse. Perhaps some independent eﬀects of the non-catalytic
C2 domain of PTEN [36] can aﬀect SopE function. Addition-
ally, PTEN can modulate the expression of many diﬀerent pro-
teins, notably including Rac [37], through which SopE exerts
its eﬀects upon the cytoskeleton [18].3.4. Concluding comments
Salmonella utilizes a very sophisticated arsenal of virulence
proteins to hijack the host’s signal transduction systems, so
as to invade and proliferate within host-cells. One particularly
striking aspect of this pathogenicity is an ability to deplete the
cellular pool of InsP5 [4–6]; no other stimulus is known that
can elicit changes in cellular InsP5 levels at either the rate or
the magnitude of that stimulated by Salmonella. Previous stud-
ies [4] have shown that SopE plays some role in depleting InsP5
levels. In the current study, we have come to two new impor-
tant conclusions concerning the action of SopE: First, InsP5
dephosphorylation within the host-cell is not promoted by
SopE itself, nor is it the result of an interaction of SopE with
host proteins. It now seems likely that the contribution that
SopE makes to accelerating InsP5 depletion when the entire
bacterium invades cells [4], requires an interaction of SopE
with other Salmonella virulence proteins.
The second major conclusion to arise from this study is that
SopE-dependent remodeling of the actin cytoskeleton occurs
independently of changes in inositol phosphate turnover. ThisSopE
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e Fig. 4) were either mock-transfected (‘‘control’’) or transfected with
idin, to identify actin. Some muristerone-treated cell cultures were also
opE) and then inositol phosphate levels were ascertained by HPLC
1714 S. Deleu et al. / FEBS Letters 580 (2006) 1709–1715is the ﬁrst time that these two eﬀects of SopE have been func-
tionally separated. This result has wider ramiﬁcations; it indi-
cates that the host-cell cytoskeletal rearrangements and InsP5
depletion caused by another Salmonella virulence protein,
SopB [4], are also not directly functionally linked. Perhaps
actin remodeling by Salmonella is served by manipulating the
turnover of inositol lipids [17,38], rather than the inositol
phosphates.
Our work should serve to focus greater attention on alter-
nate biological consequences that might arise when Salmonella
perturbs inositol phosphate metabolism. For example, InsP5
antagonizes the Akt protein kinase [9]. Therefore, loss of cellu-
lar InsP5 may underlie the ability of Salmonella to activate Akt
and promote cell survival during infection [13]. Dephosphoryl-
ation of InsP5 to Ins(1,4,5,6)P4 during Salmonella invasion also
manipulates ion channel activities in the plasma membrane
[5,6,14,15]. It is possible that this may also serve to inhibit
host-cell apoptosis [16]. Additionally, changes in ion channel
conductance can accelerate salt and ﬂuid secretion from intes-
tinal epithelial cells [14]. Induction of secretary diarrhoea helps
Salmonella to leave its current host, and to facilitate the loca-
tion and colonization of new organisms.
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